24/7 Patient Assistance: 760-405-8205

Sandip Patel, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Sandip Patel graduated from the Baylor College of Medicine and completed his residency program at the UCLA Medical Center. Then, he did a fellowship at the Duke University Hospital. He is specialized in Medical Oncology and board certified in Internal Medicine, Hematology and Oncology. Dr. Patel has been in practice for more than 6 years and is affiliated with the UC San Diego Health System. During his career, he has also contributed to 8 clinical research publications.

  • Education & Training


    Baylor College of Medicine

    Medical School


    UCLA Medical Center



    Duke University Hospital


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UC San Diego Health System

    Languages: English/Spanish

    (858) 657-7000

    200 West Arbor Drive

    San Diego, California 92103

    Read More
  • Publications & Memberships

    Dr. Sandip Patel has contributed to 3 publications.

    PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.

    Patel, S. P.,Kurzrock, R.; Mol. Cancer Ther.. 2015 Feb 20.

    See more >>

    CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1.

    Osada, T.,Patel, S. P.,Hammond, S. A.,Osada, K.,Morse, M. A.,Lyerly, H. K.; Cancer Immunol. Immunother.. 2015 Mar 07.

    See more >>

    Best practices for the Management of Local-regional Recurrent Chordoma. A Position Paper by the Chordoma Global Consensus Group.

    Stacchiotti, S.,Gronchi, A.,Fossati, P.,Akiyama, T.,Alapetite, C.,Baumann, M.,Blay, J. Y.,Bolle, S.,Boriani, S.,Bruzzi, P.,Capanna, R.,Caraceni, A.,Casadei, R.,Colia, ...; Ann. Oncol.. 2017 Feb 12. CEA/CD3-bispecific T cell-engaging (BiTE) antibody-

    See more >>